An NCI-designated Comprehensive Cancer Center, affiliated with the University of Pittsburgh School of Medicine
Research
This research highlight focuses on Lyn Robertson, DrPH, MSN, BSN — Director of Cancer Screening and External Partnerships for Health Equity and Community Outreach and Engagement at UPMC Hillman Cancer Center. One of Dr. Robertson’s main areas of interest is…
The University of Pittsburgh was awarded a five-year, $11.2 million grant from the National Institutes of Health (NIH) to support a Head and Neck Cancer Specialized Program of Research Excellence (SPORE) in 2022. The award will be led by Robert…
Jason J. Luke, MD, FACP, will be the Interim Associate Director for Clinical Research at UPMC Hillman Cancer Center beginning February 1, 2023. Dr. Luke is currently Director of Hillman’s Immunotherapy and Drug Development Center and a member of the…
In 2022, we at UPMC Hillman Cancer Center greatly expanded the capabilities for the research that is done here every day to envision life without cancer. We expanded our footprint, welcomed exceptional leadership and faculty to our center, and launched…
Norman Wolmark, MD, FACS, FRCSC, a member of the leadership team at UPMC Hillman Cancer Center and professor of surgery at the University of Pittsburgh, has been awarded the 2022 Brinker Award for Scientific Distinction in Clinical Research from Susan…
Steffi Oesterreich, PhD, is a researcher at UPMC Hillman Cancer Center who focuses her work on better understanding how to most effectively treat breast cancers, including invasive lobular carcinoma (ILC) and estrogen receptor-positive (ESR1) breast cancer resistant to hormonal therapies. …
